Biotechnology | Indenture Agreements | Business Contracts

Indenture, dated as of March 7, 2023, between Invitae Corporation, the guarantor parties thereto and U.S. Bank Trust Company, National Association, as trustee and collateral agent (Invitae Corp, Filed With SEC on March 8, 2023)

Form of New Notes Indenture (Invitae Corp, Filed With SEC on March 1, 2023)

Fourth Supplemental Indenture, dated March 1, 2023, between the Company and U.S. Bank National Association, as Trustee (including the form of 2.00% Convertible Senior Notes due... (EXACT SCIENCES CORP, Filed With SEC on March 1, 2023)

Indenture, dated as of December 20, 2022, between Novavax, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (NOVAVAX INC, Filed With SEC on December 21, 2022)

Indenture, dated as of September 15, 2022, between the Registrant (ALNYLAM PHARMACEUTICALS, INC., Filed With SEC on October 27, 2022)

First Supplemental Indenture, dated as of October 5, 2022, between Global Blood Therapeutics, Inc. and U.S. Bank Trust Company, National Association, as trustee (Global Blood Therapeutics, Inc., Filed With SEC on October 5, 2022)

Indenture, dated as of September 16, 2022, by and between Sarepta Therapeutics, Inc. and U. S. Bank Trust Company, National Association (including the form of the 1.250%... (Sarepta Therapeutics, Inc., Filed With SEC on September 19, 2022)

Indenture, dated as of September 15, 2022, between Alnylam Pharmaceuticals, Inc. and The Bank of New York Mellon, as trustee (ALNYLAM PHARMACEUTICALS, INC., Filed With SEC on September 16, 2022)

Indenture, dated August 18, 2022 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (HALOZYME THERAPEUTICS INC, Filed With SEC on August 18, 2022)

Indenture, dated as of August 16, 2022, between Cerevel Therapeutics Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee (ARYA Sciences Acquisition Corp II, Filed With SEC on August 16, 2022)

Second Supplemental Indenture, dated August 15, 2022, by and between Radius Health, Inc. and Wilmington Trust, National Association, as trustee (Radius Health, Inc., Filed With SEC on August 15, 2022)

Indenture, dated as of July 6, 2022, between Cytokinetics, Incorporated and U.S. Bank Trust Company, National Association, as trustee (Cytokinetics, Incorporated, Filed With SEC on July 6, 2022)

Consent Under and Amendment No. 4 to Indenture, dated June 3, 2022, by and among Sorrento Therapeutics, Inc., Scilex Pharmaceuticals Inc., U.S. Bank Trust Company, National... (Sorrento Therapeutics, Inc., Filed With SEC on June 3, 2022)

Second Supplemental Indenture, dated March 11, 2022, between the Company and U.S. Bank Trust Company, National Association, as Trustee (including the form of 2.25% Convertible... (Retrophin, Inc., Filed With SEC on March 11, 2022)

Amendment No. 3 to Indenture of Lease, between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated August 24, 2021 (Beam Therapeutics Inc., Filed With SEC on February 28, 2022)

Amendment No. 2 to Indenture of Lease, between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated November 17, 2020 (Beam Therapeutics Inc., Filed With SEC on February 28, 2022)

Amendment No. 1 to Indenture of Lease, between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated April 14, 2020 (Beam Therapeutics Inc., Filed With SEC on February 28, 2022)

First Supplemental Indenture, dated as of December 22, 2021, by and between the Company and U.S. Bank National Association, as Trustee (NEUROCRINE BIOSCIENCES INC, Filed With SEC on February 11, 2022)

Indenture, dated as of December 17, 2021, between Global Blood Therapeutics, Inc. and U.S. Bank National Association, as trustee (Global Blood Therapeutics, Inc., Filed With SEC on December 17, 2021)

First Supplemental Indenture, dated as of November 19, 2021, by and between Flexion Therapeutics, Inc. and Wells Fargo Bank, National Association, as trustee (Flexion Therapeutics Inc, Filed With SEC on November 19, 2021)

First Supplemental Indenture, dated as of November 9, 2021, by and between Kadmon Holdings, Inc. and U.S. Bank National Association, as Trustee (Kadmon Holdings, Inc., Filed With SEC on November 9, 2021)

Indenture of Lease by and between the Registrant and Revolution Labs Owner, LLC, dated September 7, 2021 (Keros Therapeutics, Inc., Filed With SEC on November 4, 2021)

Third Supplemental Indenture, dated as of August 24, 2021, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust Company,... (Protalix BioTherapeutics, Inc., Filed With SEC on August 26, 2021)

First Supplemental Indenture, dated as of August 17, 2021, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee and as collateral agent (INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on August 23, 2021)

Indenture, dated as of August 17, 2021, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee (INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on August 23, 2021)

Second Supplemental Indenture, dated as of May 13, 2021, by and between the Company and Wells Fargo Bank, National Association (INSMED Inc, Filed With SEC on May 13, 2021)

Indenture, dated as of May 13, 2021, by and between Dynavax Technologies Corporation and U.S. Bank National Association, as Trustee (DYNAVAX TECHNOLOGIES CORP, Filed With SEC on May 13, 2021)

First Supplemental Indenture, dated as of April 30, 2021, by and among Avid SPV, LLC, Avid Bioservices, Inc. and U.S. Bank National Association (Avid Bioservices, Inc., Filed With SEC on May 5, 2021)

Indenture, dated as of April 12, 2021, by and between the Company and U.S. Bank National Association, as Trustee (IONIS PHARMACEUTICALS INC, Filed With SEC on April 13, 2021)

Indenture, dated as of April 8, 2021, between Invitae Corporation and U.S. Bank National Association (including form of Note) (Invitae Corp, Filed With SEC on April 8, 2021)

Investment Agreement, dated as of April 3, 2021, by and among Invitae Corporation and parties listed therein (including form of Indenture relating to 1.50% Convertible Senior... (Invitae Corp, Filed With SEC on April 5, 2021)

Indenture, dated as of March 12, 2021, by and among Avid SPV, LLC, Avid Bioservices, Inc. and U.S. Bank National Association, as trustee relating to the 1.250% Exchangeable Senior... (Avid Bioservices, Inc., Filed With SEC on March 12, 2021)

Indenture, dated as of March 4, 2021, by and between MannKind Corporation and U.S. Bank National Association, as Trustee (MANNKIND CORP, Filed With SEC on March 5, 2021)

Indenture of Lease by and between MIT 314 Main Street Leasehold LLC and Zai Lab (US) LLC dated December 22, 2020 (Zai Lab Ltd, Filed With SEC on March 1, 2021)

Indenture of Lease, dated November 3, 2020, by and between the Registrant and Boston Properties Limited Partnership (Translate Bio, Inc., Filed With SEC on March 1, 2021)

Indenture, dated March 1, 2021 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (HALOZYME THERAPEUTICS INC, Filed With SEC on March 1, 2021)

Third Supplemental Indenture, dated February 16, 2021, between Biogen Inc. and U.S. Bank National Association (Biogen Inc., Filed With SEC on February 16, 2021)

Second Supplemental Indenture, dated April 30, 2020, between Biogen Inc. and U.S. Bank National Association, including the forms of Global Notes attached as Exhibit A and Exhibit... (Biogen Inc., Filed With SEC on February 3, 2021)

Indenture, dated as of January 28, 2021, by and between BridgeBio Pharma, Inc. and U.S. Bank National Association, as Trustee (BridgeBio Pharma, Inc., Filed With SEC on January 29, 2021)

Indenture, dated as of December 7, 2020, between Progenity, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (PROGENITY, INC., Filed With SEC on December 7, 2020)

Biotechnology (86) | Indenture Agreements (86)